Oxaliplatin: a new therapeutic option in colorectal cancer.

Seminars in oncology, 1999 - europepmc.org
Oxaliplatin (Eloxatin; Sanofi, Gentilly, France), a third-generation platinum compound with a
1, 2-diaminocyclohexane (DACH) carrier ligand, is a recently developed agent with activity …
被引用次数：185 相关文章

[引用][C] Oxaliplatin: A new therapeutic option in colorectal cancer

E CVITKOVIC, M BEKRADDA - Seminars in oncology, 1999 - pascal-francis.inist.fr
Oxaliplatin : A new therapeutic option in colorectal cancer CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

Oxaliplatin: a new therapeutic option in colorectal cancer

E Cvitkovic, M Bekradda - Seminars in oncology, 1999 - pubmed.ncbi.nlm.nih.gov
Oxaliplatin (Eloxatin; Sanofi, Gentilly, France), a third-generation platinum compound with a
1, 2-diaminocyclohexane (DACH) carrier ligand, is a recently developed agent with activity …

[引用][C] Oxaliplatin: A new therapeutic option in colorectal cancer

E CVITKOVIC, M BEKRADDA - Seminars in oncology, 1999 - Elsevier